Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Comment by BlindBoyon Nov 22, 2006 5:25pm

287 Views

Post# 11731975

RE: hard to believe

a 15000 metre drill program is incredibly ambitious for a 20 cent stock: I doubt they would attempt such a grand scale if they didn't have confidence that there was something there. wish I had been on the bid when TD dumped. I went on the bid thereafter, but only got a pittance. Oh well ... I'll nickel and dime my way to a reasonable position.

Bullboard Posts

FE Battery Metals begins 2024 winter drill program